Moody’s places Presence Health’s ‘Baa2’ rating on review for downgrade

Moody’s Investors Service has placed Chicago-based Presence Health’s “Baa2” rating on review for downgrade, affecting approximately $503 million of debt.

Advertisement

The review will focus on Presence Health’s quality of earnings and demonstration of internal accounting processes.

More articles on healthcare finance:
Medicare payment overhaul proposal draws opposition from industry stakeholders
Sutter Health sees net income fall 80% in 2015
Anthelio Healthcare awarded top HIM outsourcing company by Black Book

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.